CONDENSED CONSOLIDATED STATEMENTS OF OPERATIONS AND COMPREHENSIVE LOSS (Unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2024	Mar. 31, 2023
Operating expenses:
Research and development	$ 19,970	$ 11,880
General and administrative	6,017	4,538
Total operating expenses	25,987	16,418
Loss from operations	(25,987)	(16,418)
Other income (expense), net
Interest income	3,250	1,694
Other expense	(1)	0
Total other income (expense), net	3,249	1,694
Net loss	(22,738)	(14,724)
Other comprehensive income (loss):
Net unrealized losses on marketable securities	(194)	0
Comprehensive loss	$ (22,932)	$ (14,724)
Net loss per share, basic	$ (0.54)	$ (0.8)
Net loss per share, diluted	$ (0.54)	$ (0.8)
Weighted-average shares outstanding, basic	42,045,608	18,514,644
Weighted-average shares outstanding, diluted	42,045,608	18,514,644